NatWest Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-91,069
| Closed | -$458K | – | 402 |
|
|
2015
Q3 | $458K | Buy |
+91,069
| New | +$458K | 0.01% | 291 |
|
|
2015
Q2 | – | Sell |
-91,069
| Closed | -$641K | – | 459 |
|
|
2015
Q1 | $641K | Buy |
91,069
+20,444
| +29% | +$144K | 0.01% | 283 |
|
|
2014
Q4 | $545 | Buy |
70,625
+34,420
| +95% | +$266 | ﹤0.01% | 299 |
|
|
2014
Q3 | $270 | Hold |
36,205
| – | – | ﹤0.01% | 450 |
|
|
2014
Q2 | $350K | Sell |
36,205
-9,788
| -21% | -$94.6K | 0.01% | 410 |
|
|
2014
Q1 | $382K | Sell |
45,993
-1,536
| -3% | -$12.8K | 0.02% | 380 |
|
|
2013
Q4 | $401K | Sell |
47,529
-16,514
| -26% | -$139K | 0.01% | 605 |
|
|
2013
Q3 | $510K | Buy |
64,043
+5,117
| +9% | +$40.7K | 0.01% | 704 |
|
|
2013
Q2 | $455K | Buy |
+58,926
| New | +$455K | 0.01% | 611 |
|